CH391L/S12/Bioprospecting: Difference between revisions
| Line 6: | Line 6: | ||
==Metagenomics== | ==Metagenomics== | ||
Metagenomics uses Next Generation Sequencing Technologies (e.g., Roche 454, Illumina, ABI SoliD) to completely sample the genomes of mixed microbial communities, generating an unbiased view of genomic sequence space. The current explosion in various Metagenomic projects (340 current projects [[http://www.genomesonline.org/cgi-bin/GOLD/index.cgi GOLD database]]) permits for entirely in silico approaches to identifying new gene families, with potential as parts in Synthetic Biology. | Metagenomics uses Next Generation Sequencing Technologies (e.g., Roche 454, Illumina, ABI SoliD) to completely sample the genomes of mixed microbial communities, generating an unbiased view of genomic sequence space. The current explosion in various Metagenomic projects (340 current projects, 1990 sampels [[http://www.genomesonline.org/cgi-bin/GOLD/index.cgi GOLD database]]) permits for entirely in silico approaches to identifying new gene families, with potential as parts in Synthetic Biology. | ||
====Craig Venter and his Yacht==== | ====Craig Venter and his Yacht==== | ||
Revision as of 21:30, 25 January 2012
What's Bioprospecting?
Bioprospecting is a catch-all term for activities including discovery, acquisition, and utilization of novel biomaterials. This has historically been a controversial activity, often leading to unregulated commercialization of fauna (e.g., plants and medicinals) from third world countries for the benefit of commercial interests [Pros/Cons of Bioprospecting]. However, as a term in Molecular Biology, it reflects the growing need to discover new types of protein and nucleic acid parts, which can be used in biotechnology and basic research. The advent of multiple Next-Generation Sequencing technologies since 2006 now provides depth of information into the entire genomes (Metagenomics) of species previously inaccessible to basic research. [1][2]
GFP
Although not planned, one of the great examples of Bioprospecting is the story of Green Fluorescent Protein (GFP), a protein that has had a profound impact on every major field in modern biology. Originally isolated and characterized by Osamu Shimomura in the 1960's and 1970's from jellyfish and sea pansies, it was a mere oddity that conferred the eery bioluminescence of certain deep sea creatures. However, the subsequent cloning of the gene by Martin Chalfie and improvement into enhanced GFP by Roger Tsien made one of the modern workhorses in biology. This 40 year journey earned Shimomura, Chalfie, and Tsien the 2008 Nobel Prize in Chemistry. [History of GFP]
Metagenomics
Metagenomics uses Next Generation Sequencing Technologies (e.g., Roche 454, Illumina, ABI SoliD) to completely sample the genomes of mixed microbial communities, generating an unbiased view of genomic sequence space. The current explosion in various Metagenomic projects (340 current projects, 1990 sampels [GOLD database]) permits for entirely in silico approaches to identifying new gene families, with potential as parts in Synthetic Biology.
Craig Venter and his Yacht
The Sorcerer II is Craig Venter's personal Yacth, used to scan the seas for novel marine microbiota. [3]
The human gut microbiome
Successful examples of Bioprospecting using Metagenomics
Uses of New Parts
Limitations
References
<biblio>
- Review1 pmid=21497084 Metagenomics and the protein universe
- Review2 pmid=20495950
- SorcererII pmid=17355171
- Bovineome pmid=19181843
- Cows pmid=21273488
